Sault Ste. Marie, Canada Clinical Trials

A listing of Sault Ste. Marie, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 52 clinical trials
Web-Based Assessment Validation and Engagement Study

This study is looking for people who are over the age of 55 and have mild cognitive impairment or dementia. The study is also looking for people with normal cognition, as a comparison. The study is investigating a new computerized assessment.

Accepts healthy volunteers
cognitive assessment
cognitive impairment
mild cognitive impairment
Online studies
Online Study Center
(online study) Contact site
  • 1713 views
  • 23 Sep, 2022
  • 1 location
  • Online study
Promoting Reengagement in Daily Meaningful Activity Intervention for adults with mild cognitive impairment and their caregivers

The PRIMA project is design to help persons with mild cognitive impairment to help them to improve their engagement in personally meaningful activity and improve their overall quality of life with their family caregivers support. The goal of PRIMA project is to increase persons with mild cognitive impairment’s engagement in …

Accepts healthy volunteers
Online studies
Online Study Center
(online study) Contact site
  • 371 views
  • 23 Sep, 2022
  • 1 location
  • Online study
Alzheimer's Disease Center Research Registry

This study is looking for people over the age of 55 who have normal cognition, memory problems, or mild dementia. The study is also looking for people who are care partners of someone who has dementia. The study is intended to match people with studies that may be a good …

Accepts healthy volunteers
Online studies
mild dementia
Online Study Center
(online study) Contact site
  • 386 views
  • 23 Sep, 2022
  • 1 location
  • Online study
Objective, Passive Assessment of LRRK2 Carriers (OPAL)

This study is currently only open to active participants in the University of Rochester’s VALOR-PD study. The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wireless …

movement disorder
Online studies
University of Rochester
(online study) Contact site
  • 64 views
  • 12 May, 2022
  • 1 location
  • Online study
A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Patients With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer

This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant giredestrant compared with endocrine therapy of physician's choice in participants with medium- and high-risk Stage I-III histologically confirmed estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative early breast cancer.

University of Michigan
 (293.6 away) Contact site
  • 19 views
  • 19 Sep, 2022
  • +597 other locations
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer (TAILOR RT)

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming …

adjuvant chemotherapy
sentinel lymph node biopsy
endocrine therapy
carcinoma
breast-conserving surgery
Algoma District Cancer Program Sault Area Hospital
 (2.2 away) Contact site
  • 760 views
  • 27 Jul, 2022
  • +325 other locations
A Phase I/II Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-01)

This study is a phase I/II open-label study in patients with relapsed indolent NHL (Part A) or relapsed/refractory FL (Part B). Part A of the study assessed the safety and preliminary efficacy. This seamless design study now has four parts: 1) Part A, Ph I - dose escalation, 2) Part …

indolent non-hodgkin lymphoma
measurable disease
refractory follicular lymphoma
alkylating agent
follicular lymphoma
Sault Area Hospital
 (2.2 away) Contact site
  • 406 views
  • 24 Jan, 2022
  • +93 other locations
A Randomized, Multicenter, Open-Label Cross-Over Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer

This is a Phase II, randomized, multi-center, multinational, open-label, cross-over study in adult participants with PD-L1-positive NSCLC. Two populations will be included: participants with resected Stage IIB-IIIB (early-stage) NSCLC who have completed adjuvant platinum-based chemotherapy without evidence of disease relapse/recurrence, and chemotherapy-naïve participants with Stage IV NSCLC. The study will …

atezolizumab
adjuvant chemotherapy
chemoradiotherapy
cancer chemotherapy
lung carcinoma
Royal Victoria Regional Health Centre; c/o Oncology Clinical Trials
 (268.5 away) Contact site
  • 1 views
  • 14 Sep, 2022
  • +40 other locations
A Phase 3 Open-label Trial of Neoadjuvant Trastuzumab Deruxtecan (T-DXd) Monotherapy or T-DXd Followed by THP Compared to ddAC-THP in Participants With High-risk HER2-positive Early-stage Breast Cancer (DESTINY-Breast11)

This study will look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast cancer.

paclitaxel
mammogram
trastuzumab
magnetic resonance imaging of breast
cyclophosphamide
Research Site
 (2.2 away) Contact site
  • 5 views
  • 15 Sep, 2022
  • +76 other locations
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Patients With Previously Untreated Advanced Non-Squamous Non-Small-Cell Lung Cancer (SKYSCRAPER-06)

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of tiragolumab in combination with atezolizumab plus pemetrexed and carboplatin/cisplatin (Arm compared with placebo in combination with pembrolizumab plus pemetrexed and carboplatin/cisplatin (Arm B) in participants with previously untreated, locally advanced unresectable or metastatic non-squamous non-small cell …

chemoradiotherapy
measurable disease
lung carcinoma
atezolizumab
pembrolizumab
Sault Area Hospital; Algoma District Cancer Program
 (2.2 away) Contact site
  • 86 views
  • 15 Sep, 2022
  • +33 other locations